1. Regeneron starting late stage trials of coronavirus drug cocktail — Bristol-Myers pays Dragonfly Therapeutics $55M to bring NK cells to neuro diseases — JNJ in $480M-plus deal with Emergent for coronavirus vaccine supply — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Please take our quick survey on how COVID-19 is impacting your job It will only take a minute or two to respond. The survey is confidential, and does not require registration. Thank you in advance for your participation. We will provide regular updates on results as responses accumulate.
    Dismiss Notice

Create Thread

Anonymous board for Eurofins

Verification:

(CustomImgCaptcha By Surrey Forum)

Tags:

Multiple tags may be separated by commas.

Post a Poll

Possible Responses:
Maximum Selectable Responses:

This is the maximum number of responses a voter may select when voting.

Options: